Biohaven Pharmaceutical Holding Company Ltd Biohaven (NYSE: BHVN) Signs License and Research Collaboration Agreement with KU Leuven Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) disclosed that its business unit Biohaven Therapeutics Ltd has inked an exclusive global license and research agreement with KU Leuven to develop and
